AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Biofield Corp. (BZET) announced the appointment of Bianucci di Bianucci & C. snc. as the exclusive distributor in Italy of the Biofield Diagnostic System (BDS). The appointment, which is subject to minimum annual purchases, is for a 3-year period.
The BDS enables a healthcare provider to perform a 15-minute noninvasive office-based test that delivers an immediate result, which assists in characterizing the severity of a breast lesion. Such characterization may assist in the prioritization of appropriate care and lead to a reduction in the number biopsies and other invasive procedures performed on women to diagnose breast cancer.
"Italy has one of the highest rates of breast cancer in Europe," said Stefano Bianucci, managing director of the Bianucci company, "and the BDS test offers a proven, accurate, rapid and painless option for the women of Italy. Our clinical and engineering team and I have been involved in supporting Biofield's clinical trials in ...